Renalytix Stock Quote RNLX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.2824

Bid

0.2662

Ask

0.291

Volume

230,172

0.2647 Day's Range 0.29

0.00 52 Week Range 0.00

Market Cap

23.429M

Previous Close

0.2626

Open

0.29

Last Trade

0.29

Last Trade Time

Financial Volume

$ 65,881

VWAP

0.286227

Average Volume (3m)

Shares Outstanding

82,962,757

Dividend Yield

PE Ratio

-0.17

Earnings Per Share (EPS)

-0.56

Revenue

3.4M

Net Profit

-46.22M

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease ... Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. Show more

Sector

Services, Nec

Industry

Services, Nec

Website

renalytix.com

Headquarters

London, Gbr

Founded

Renalytix PLC is listed in the Services sector of the NASDAQ with ticker RNLX. The last closing price for Renalytix was $0.26. Over the last year, Renalytix shares have traded in a share price range of $ 0.00 to $ 0.00.

Renalytix currently has 82,962,757 shares outstanding. The market capitalization of Renalytix is $21.79 million. Renalytix has a price to earnings ratio (PE ratio) of -0.17.

FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

Form 8-K - Current report

Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

LONDON and NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MSSMaison Solutions Inc	$ 1.58 (120.98%)	101.72M
BNZIBanzai International Inc	$ 8.24 (96.19%)	62.37M
XHGXChange TED Inc	$ 1.175 (89.67%)	29.88M
SEELSeelos Therapeutics Inc	$ 0.295 (55.26%)	335.52M
WVEWave Life Sciences Ltd	$ 8.18 (53.18%)	15.73M
BIVIBioVie Inc	$ 1.1719 (-58.15%)	2.87M
GHSIGuardion Health Sciences Inc	$ 6.55 (-37.74%)	379.43k
FCUVFocus Universal Inc	$ 0.2371 (-28.15%)	2.86M
XPONExpion360 Inc	$ 0.0861 (-26.41%)	49.82M
TOIIWOncology Institute Inc	$ 0.0142 (-24.06%)	58.76k
NVDANVIDIA Corporation	$ 120.87 (3.97%)	354.91M
SEELSeelos Therapeutics Inc	$ 0.295 (55.26%)	335.52M
SQQQProShares UltraPro Short QQQ	$ 7.65 (-1.54%)	135.88M
INTCIntel Corporation	$ 22.81 (1.11%)	113.11M
MSSMaison Solutions Inc	$ 1.58 (120.98%)	101.72M